Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06647524 · ClinicalTrials.gov registry record · Phase 2
Pilot fMRI Studies of Aging-Related Effects of THC
A Phase 2 study of THC, sponsored by Yale University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06647524 is a Phase 2 study of THC that is actively recruiting participants, run by Yale University. The registered enrollment target is 10 participants, below the 56-participant average among 9 other THC trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06647524, a Phase 2 study of THC, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to begin investigating acute impairment of various forms of memory and learning by Tetrahydrocannabinol (THC) in cannabis (CNB) compared to placebo, in a 2-session per subject double-blind, random assignment, placebo-controlled counterbalanced design in young to middle-aged adults.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG THC
Study Locations (1)
Connecticut
- Olin Neuropsychiatric Research Center at Hartford Healthcare - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06647524
The ClinicalTrials.gov registry entry for NCT06647524 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 9 other THC trials with a reported enrollment target (82% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with THC appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06647524 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06647524 about?
NCT06647524 is a clinical study titled "Pilot fMRI Studies of Aging-Related Effects of THC". The purpose of this study is to begin investigating acute impairment of various forms of memory and learning by Tetrahydrocannabinol (THC) in cannabis (CNB) compared to placebo, in a 2-session per subject double-blind, random assignment, placebo-controlled counterbalanced design in young to middle-a...
What is the current status of trial NCT06647524?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2025-07-01. Estimated completion is 2027-12.
What conditions does trial NCT06647524 study?
This clinical trial studies the following conditions: THC.
What interventions are being tested in trial NCT06647524?
The interventions under investigation include: Placebo (DRUG), THC (DRUG).
Who is sponsoring clinical trial NCT06647524?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06647524 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for THC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
RECRUITING · Phase 2
-
Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
RECRUITING · Phase 2
-
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
COMPLETED · Phase 2
-
Behavioral Pharmacology of Orally Administered THC and D-limonene
RECRUITING · Phase 1
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Probing the Cannabinoid System in Individuals With a Family History of Psychosis
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.